JIUYUAN GENE Finalises Corporate Rebranding to Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.

Bulletin Express
05/11

Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (stock short name: JIUYUAN GENE) has completed its previously announced corporate name change. According to the board announcement dated 11 May 2026, the Registrar of Companies in Hong Kong issued a Certificate of Registration of Alteration of Name on 17 April 2025, confirming the switch from “Hangzhou Jiuyuan Gene Engineering Co., Ltd.” to “Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.” The Chinese name was simultaneously updated from “杭州九源基因工程股份有限公司” to “杭州九源基因生物醫藥股份有限公司”.

The rebranding does not affect shareholder rights, daily operations or the company’s financial position. All existing share certificates bearing the former name remain valid for trading, settlement, registration and delivery. From 15 April 2025, newly issued share certificates carry the new corporate name; there is no arrangement for exchanging previously issued certificates.

The company’s stock code (02566) and its Chinese (九源基因) and English (JIUYUAN GENE) trading abbreviations remain unchanged.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10